Former NFL star Brett Favre has been in the news recently after he revealed he’s been diagnosed with Parkinson’s disease. As ...

A study of Parkinson’s Disease patients undergoing DBS reveals that 40% develop peri-electrode oedema, with asleep surgery ...

GOLDEN, Colo. — For 12 years, Paul Stroud’s done everything he can to combat the effects of Parkinson’s disease. He had a ...

Penn Medicine researchers will advance their understanding of the underlying causes of cognitive decline in individuals with Lewy body diseases, like Parkinson's, and identify biomarkers that predict ...

Why a Malvern biopharma is exploring combining its lead drug candidate targeting Alzheimer's and Parkinson's diseases with a ...

On Tuesday, former Packers football player, Brett Favre announced he suffers from Parkinson’s Disease. Parkinson’s Disease is ...

Bayer Ag BAYRY and its wholly owned subsidiary BlueRock Therapeutics LP announced positive 24-month data from an early-stage ...

A Parkinson’s Love Story” is told from the perspectives of the author as wife, mother, friend, perceptive memoirist and ...

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease ...

Parkinson's disease a common but complex neurodegenerative disorder that affects 10 million people worldwide. Here are some ...

Researchers conducted a retrospective cohort study to compare the effects of SGLT-2 inhibitors and DPP-4 inhibitors on Parkinson disease risk among adults with T2D.

More than 20 years later, Alberts and a team of researchers have received a $3 million, five-year award from the National ...